Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
SSY Group ( (HK:2005) ) has issued an announcement.
SSY Group Limited has announced that its caffeine product has received the Certificate of Suitability to the European Pharmacopoeia monograph (CEP) from the European Directorate for the Quality of Medicines and HealthCare. This certification is expected to enhance the company’s international sales, brand image, and market share, particularly in European and American markets, by meeting high production and quality standards.
The most recent analyst rating on (HK:2005) stock is a Buy with a HK$7.00 price target. To see the full list of analyst forecasts on SSY Group stock, see the HK:2005 Stock Forecast page.
More about SSY Group
SSY Group Limited operates in the pharmaceutical industry, focusing on the production of bulk pharmaceuticals and additives such as caffeine, which are utilized in the pharmaceutical, food, and beverage sectors.
Average Trading Volume: 12,658,378
Technical Sentiment Signal: Sell
Current Market Cap: HK$8.53B
For detailed information about 2005 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue